Gene · 7399
Papers2,630
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,021 to 1,040 of 2,630
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Genetic Variability of Human Cytomegalovirus Clinical Isolates Correlates With Altered Expression of Natural Killer Cell-Activating Ligands and IFN-γ. | Front Immunol | 2021 | 33897679 | PubTator, text mining | PubMed |
| Antisense oligonucleotide-based treatment of retinitis pigmentosa caused by USH2A exon 13 mutations. | Mol Ther | 2021 | 33895329 | PubTator, text mining | PubMed |
| Homology modeling and global computational mutagenesis of human myosin VIIa. | J Anal Pharm Res | 2021 | 33889793 | PubTator, text mining | PubMed |
| Efficiency of whole-exome sequencing in old world and new world primates using human capture reagents. | J Med Primatol | 2021 | 33876458 | PubTator, text mining | PubMed |
| Recombinant pseudorabies virus with gI/gE deletion generated by overlapping polymerase chain reaction and homologous recombination technology induces protection against the PRV variant PRV-GD2013. | BMC Vet Res | 2021 | 33853597 | PubTator, text mining | PubMed |
| Molecular genetics of inherited retinal degenerations in Icelandic patients. | Clin Genet | 2021 | 33851411 | PubTator, text mining | PubMed |
| mTOR/EGFR/iNOS/MAP2K1/FGFR/TGFB1 Are Druggable Candidates for N-(2,4-Difluorophenyl)-2',4'-Difluoro-4-Hydroxybiphenyl-3-Carboxamide (NSC765598), With Consequent Anticancer Implications. | Front Oncol | 2021 | 33842373 | PubTator, text mining | PubMed |
| Genetic variants related to successful migraine prophylaxis with verapamil. | Mol Genet Genomic Med | 2021 | 33829662 | PubTator, text mining | PubMed |
| Sunglasses to hide behind may also prevent melanoma of the eyes. | Br J Cancer | 2021 | 33824477 | PubTator, text mining | PubMed |
| A slowly cleaved viral signal peptide acts as a protein-integral immune evasion domain. | Nat Commun | 2021 | 33824318 | PubTator, text mining | PubMed |
| FAT3 Mutation Is Associated With Tumor Mutation Burden and Poor Prognosis in Esophageal Cancer. | Front Oncol | 2021 | 33816234 | PubTator, text mining | PubMed |
| Aristolochic acid-associated urinary tract cancers: an updated meta-analysis of risk and oncologic outcomes after surgery and systematic review of molecular alterations observed in human studies. | Ther Adv Drug Saf | 2021 | 33815744 | PubTator, text mining | PubMed |
| Gene Therapy to the Retina and the Cochlea. | Front Neurosci | 2021 | 33815052 | PubTator, text mining | PubMed |
| New Approaches to the Prevention and Treatment of Viral Diseases. | Arch Immunol Ther Exp (Warsz) | 2021 | 33811524 | PubTator, text mining | PubMed |
| The Molecular Basis of Ubiquitin-Conjugating Enzymes (E2s) as a Potential Target for Cancer Therapy. | Int J Mol Sci | 2021 | 33810518 | PubTator, text mining | PubMed |
| Potential Impact of Human Cytomegalovirus Infection on Immunity to Ovarian Tumours and Cancer Progression. | Biomedicines | 2021 | 33808294 | PubTator, text mining | PubMed |
| A Short History of Skin Grafting in Burns: From the Gold Standard of Autologous Skin Grafting to the Possibilities of Allogeneic Skin Grafting with Immunomodulatory Approaches. | Medicina (Kaunas) | 2021 | 33801228 | PubTator, text mining | PubMed |
| The Impact of Modern Technologies on Molecular Diagnostic Success Rates, with a Focus on Inherited Retinal Dystrophy and Hearing Loss. | Int J Mol Sci | 2021 | 33799353 | PubTator, text mining | PubMed |
| Genomic and neoantigen evolution from primary tumor to first metastases in head and neck squamous cell carcinoma. | Oncotarget | 2021 | 33796222 | PubTator, text mining | PubMed |
| A novel age-informed approach for genetic association analysis in Alzheimer's disease. | Alzheimers Res Ther | 2021 | 33794991 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7399/papers?page=52